PMC:7405836 / 93695-93936
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T869","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"T870","span":{"begin":146,"end":153},"obj":"Disease"},{"id":"T871","span":{"begin":158,"end":168},"obj":"Disease"}],"attributes":[{"id":"A869","pred":"mondo_id","subj":"T869","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A870","pred":"mondo_id","subj":"T870","obj":"http://purl.obolibrary.org/obo/MONDO_0005271"},{"id":"A871","pred":"mondo_id","subj":"T871","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"CEPI has also funded Moderna to develop a vaccine for COVID-19 in partnership with the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) (182)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T861","span":{"begin":5,"end":8},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T862","span":{"begin":40,"end":41},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"CEPI has also funded Moderna to develop a vaccine for COVID-19 in partnership with the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) (182)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T652","span":{"begin":0,"end":241},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CEPI has also funded Moderna to develop a vaccine for COVID-19 in partnership with the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) (182)."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T70","span":{"begin":146,"end":153},"obj":"Phenotype"}],"attributes":[{"id":"A70","pred":"hp_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/HP_0012393"}],"text":"CEPI has also funded Moderna to develop a vaccine for COVID-19 in partnership with the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) (182)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"2560","span":{"begin":54,"end":62},"obj":"Disease"},{"id":"2561","span":{"begin":146,"end":153},"obj":"Disease"},{"id":"2562","span":{"begin":158,"end":177},"obj":"Disease"}],"attributes":[{"id":"A2560","pred":"tao:has_database_id","subj":"2560","obj":"MESH:C000657245"},{"id":"A2561","pred":"tao:has_database_id","subj":"2561","obj":"MESH:D004342"},{"id":"A2562","pred":"tao:has_database_id","subj":"2562","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CEPI has also funded Moderna to develop a vaccine for COVID-19 in partnership with the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) (182)."}